# A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer

> **NCT02590965** · PHASE2 · COMPLETED · sponsor: **Hutchison Medipharma Limited** · enrollment: 91 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Fruquintinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02590965
- **Lead sponsor:** Hutchison Medipharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-29
- **Primary completion:** 2015-08-07
- **Final completion:** 2017-02-10
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2020-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590965, "A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02590965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*